I am inclined to believe the report of the DiPALS committee is intended primarily as an alert to a possible problem and not a referendum on the pacer because they do not criticize the lead surgical team, only the United States Food and Drug Administration (possibly because their HUD/HDE approval did not take into account the possibility the pacer might be implanted but not activated).